Ophthalmologists

• Glaucoma
• Ophthalmology
  Justin Baynham was born in Houston, Texas and raised in Arlington, Virginia. He received his B.S. and M.D. from University of Virginia, and while there was elected to the Alpha Omega Alpha Honor Medical Society. After completing his internship at Georgetown University, Dr. Baynham performed his residency in Ophthalmology at the University of California, San Francisco, receiving a Heed Fellowship, the national award recognizing excellence in ophthalmology residency. His subspecialty training in vitreoretinal surgery was performed at OHSU’s Casey Eye Institute, where he was appointed Instructor in Ophthalmology. He is certified by the American Board of Ophthalmology. Dr. Baynham and his wife Allison enjoy tennis, skiing, hiking with their dog, running, and exploring the Pacific Northwest.
• Macular Degeneration
  A Phase II/III Randomized, Controlled, Double-Masked, Dose-Finding, Multi-Center, Comparative Trial in Parallel Groups, to Establish the Safety and Efficacy of Intravitreal Injections of EYE001 (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks in Patients with Exudative Age-Related Macular Degeneration. Eyetech Pharmaceuticals, Inc. – EOP 1004, Clinical Study
• Cataracts
• Eye Exam

Psychiatrists

• Mental Health
  2005 – Region Ten Mental Health Performed house visits and mental health services, Charlottesville, VA assessments on mentally ill patients in the community.

Endocrinologist

• Diabetic Retinopathy

Dermatologists

• Lesions
  2016 – Thomas AS, Baynham JT, Flaxel CJ. Macular holes, vitetlliform lesions, and midperipheral retinoschisis in Alport Syndrome. Retin Cases Brief Rep. 2016. Spring; 10(2): 109-11.